Regeneron’s Gene Therapy DB-OTO Trial Shows Promising Hearing Improvement
Investigational gene therapy DB-OTO showed promising improvements in hearing and speech development in children with otoferlin-related genetic hearing loss.
Read More
Search Results for: Regeneron
Regeneron’s Gene Therapy Improves Auditory Responses in Children with Genetic Hearing Loss
Regeneron’s trial investigating otoferlin gene therapy (DB-OTO) represents it’s first auditory program and is currently enrolling patients.
Read More
Regeneron Adds Hearing Loss Gene Therapy Program Via Decibel Therapeutics Acquisition
Regeneron Pharmaceuticals completed its acquisition of Decibel Therapeutics, strengthening the company’s gene therapy and auditory programs.
Read More
Regeneron to Acquire Decibel Therapeutics to Boost Hearing Loss Therapy Programs
Regeneron Pharmaceuticals and Decibel Therapeutics announced a definitive agreement for the acquisition of Decibel by Regeneron.
Read More
Regeneron and Decibel Therapeutics Announce Strategic Collaboration
Regeneron Pharmaceuticals Inc and Decibel Therapeutics have announced a collaboration to discover and develop new potential therapeutics to protect, repair, and restore hearing. Regeneron will provide Decibel with broad access to its proprietary suite of technologies to support Decibel’s goal of discovering important new medicines for hearing. Financial terms were not disclosed.
Read More
Clinical Trial of Gene Therapy for Genetic Hearing Loss Gets Positive Results
The trial demonstrated pharmacologic hearing restoration within 30 days of AK-OTOF gene therapy administration in the first participant.
Read More
Decibel Therapeutics Receives $82.2 Million Series D Financing for Advancement of Hearing Therapies
Proceeds will be used in part to support clinical and preclinical studies needed to advance Decibel’s therapeutic pipeline.
Read More
Best News Stories and Columns in Hearing Review, 2017
Here are 50 news items, columns, and webinars that you should not have missed in 2017 that were featured in “The Hearing Review,” along with a second list of news stories by month in 2017.
Read More